Colleges and teaching hospitals are the cornerstones of the city’s economy — and identity. But federal funding cuts to higher ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

Steve Weiss, Founder and Managing Partner of Short Hills Capital Partners joins CNBC’s “Halftime Report” to explain why he's buying the Pharmaceutical company ... Gap With China The farthest ...

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant that title regardless of what's transpired in 2025. Among them are CRISPR ...

Why is China the Talk of the Town in the ... reflecting a 12% growth versus 2023 and exceeding the company’s full-year product revenue guidance. Vertex Pharmaceuticals Incorporated (NASDAQ ...

Explore the top-performing Nasdaq 100 stocks this year as the index moves into a technical bear market this year.

Vertex is the only company of the 11 studied that is expected ... had “very low levels” of manufacturing happening in China, Mexico, and Canada. “We’d expect a very immaterial impact ...

Furthermore, CRISPR Therapeutics will share the profits generated from Casgevy with Vertex ... the company will seek to develop newer, better medicines. Merck signed an agreement with China ...

Google released a new family of AI reasoning models on March 25 under the Gemini 2.5 models, beginning with the experimental ...

Biotech companies are further pushed into making these deals due to the drying up of venture funding in China ... Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a global biotechnology ...

Google has introduced Gemini 2.5 Pro, its most advanced artificial intelligence model, designed to handle complex reasoning ...